Fig. 5From: nCoV-19 therapeutics using cucurbitacin I structural derivatives: an in silico approachRMSF of amino acid residues of protein in A nucleocapsid-CBN19 adduct and B apo structure of nucleocapsid protein derived from two separate 90 ns MDS (the four colors correspond to the four chains of the receptor and NOT to the ligands as in the other figures)Back to article page